Stockreport
One stock is dragging down the S&P 500's earnings growth [Yahoo! Finance Canada]
![Yahoo! Finance Canada](../../../Content/images/providers/Yahoo! Finance Canada.png)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Last month, the company reported a massive loss per share in the first quarter on charges related to a series of acquisitions and cut its profit forecast for the year. With 92% of S&P companies done reporting, the index is pacing for 5.4% earnings growth compared to year ago quarter, which would be the largest year-over-year earnings growth for the index since the second quarter of 2022. Take out Bristol, and the pace jumps to 8.3%, according to FactSet senior earnings analyst John Butters. Overall, the Health Care sector ( XLV ) has seen earnings decline by 25.4% from the same quarter a year ago, in line with Energy's ( XLE ) decline for the worst performance in the S&P 500 this quarter. ADVERTISEMENT When removing a few other companies from the sector, the S&P 500's earnings growth would shoot even higher. Butters also ran the numbers for the index when excluding Pfizer ( PFE ) and Gilead Sciences ( GILD ). Gilead Sciences reported a loss per share of $1.32 in the most rece
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts [Yahoo! Finance][Yahoo! Finance]
- Antiva Biosciences Announces Formation of Scientific and Development Advisory Board [Yahoo! Finance][Yahoo! Finance]
- How Luciana Preger Is Helping Advance Gilead's Work in Oncology [Yahoo! Finance][Yahoo! Finance]
- Ipsen, Genfit Medicine Is Cleared by FDA for Rare Liver Disorder [BNN Bloomberg (Canada)][BNN Bloomberg]
- Cell Therapy Market Is Expected To Reach a Revenue Of USD 32.5 Bn By 2033, At 18.6% CAGR | Dimension Market Research [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 6/11/24 - Form 4
- 6/11/24 - Form 4
- 6/11/24 - Form 4
- GILD's page on the SEC website
- More